Replies to post #448972 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Nick,

You certainly may be right. On the other hand we know in 2020 that Dr. Liau prepared a placeholder Abstract for SNO, clearly it would have to be substantially updated to work for ASCO, but I don't believe the Abstract would be a substantial effort given all that Dr. Liau has already done.

Doctors that serve as lead clinicians in major clinical trials do like to present their findings where they can discuss them with their peers. I believe that Dr. Liau is like others in this way. If a presentation fits in well with the timing of a Journal being issued, I believe she, and the company, would want to make the presentation. Certainly they're not holding the Journal up for many months to do it, but a month or so wouldn't be out of the question IMHO.

If in fact they made a presentation at ASCO and the Journal still wasn't ready, I suspect the presentation would lite a small fire under them to get it done. I don't believe that we have another Annual Meeting without the trial results being revealed, the Annual Meeting should be held in June at the latest.

Gary

[biosectinvestor]

That is also one of my beliefs, that when they talked about pandemic delays getting data it was in fact the placebo arm data they were discussing in that context. I do not know if that was the only delay, g but I believe that they referenced that delay directly. I’ll note that some of their language relating to such delays has been updated in the annual report, which came earlier than usual because they are now a much larger filer.

I also believe there is no holdup for a conference, and they have been clear about that issue.

Your take therefore is quite consistent with my own on key points.

[Bob_LobLaw]

Still finalizing the data and yet to submit the article to the journal?